Everest Medicines Announces Interim Results for First Half of 2022
- Written by PR Newswire
SHANGHAI, Aug. 24, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets, today announced its interim results for first half of 2022 along with a...
Read more: Everest Medicines Announces Interim Results for First Half of 2022














